HB 1418-FN (2018): relative establishing a commission to study greater transparency in pharmaceutical costs and drug rebate programs.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA: “HB 1418-FN (2018): relative establishing a commission to study greater transparency in pharmaceutical costs and drug rebate programs.” Granite Record, https://graniterecord.org/bill/2018/hb1418. Accessed 24 Oct. 2026.
APA: Granite Record. (n.d.). HB 1418-FN (2018): relative establishing a commission to study greater transparency in pharmaceutical costs and drug rebate programs. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2018/hb1418
Chicago: Granite Record. “HB 1418-FN (2018): relative establishing a commission to study greater transparency in pharmaceutical costs and drug rebate programs.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2018/hb1418.
BibTeX: @misc{bill-2018-hb1418, title = {HB 1418-FN (2018): relative establishing a commission to study greater transparency in pharmaceutical costs and drug rebate programs.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2018/hb1418}, note = {Accessed 24 Oct. 2026} }

HB 1418-FN (2018)

relative establishing a commission to study greater transparency in pharmaceutical costs and drug rebate programs.

Status: Signed into law
Term: 2017-2018
House committee: Commerce and Consumer Affairs
Senate committee: Health and Human Services
Subject: Study Committees and Commissions
Chapter law: 350

The Story

It was introduced on January 3, 2018 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on January 17, 2018. The committee held work sessions on January 30, 2018, February 20, 2018 and February 21, 2018. The committee met in executive session on February 21, 2018 to vote on its recommendation. The committee voted 18–1 to recommend that the House pass it with changes (amendment 2018-0782h), and the report was placed on the regular calendar. The committee's amendment (2018-0782h) was adopted on a voice vote on March 6, 2018, changing the text of the bill. On March 6, 2018 the House voted to pass it with changes on a roll call 312–17. It crossed to the Senate on March 8, 2018 and was referred to the Senate Health and Human Services committee. The committee held a public hearing on March 20, 2018. The committee recommended that the Senate pass it with changes (amendment 2018-1599s). The committee's amendment (2018-1599s) was adopted on a voice vote on April 26, 2018, changing the text of the bill. On April 26, 2018 the Senate voted to pass it with changes on a voice vote and ordered it to a third reading. On May 10, 2018 the House adopted “House Concurs with Senate Amendment 1599s” on a voice vote, on a motion by Rep. John Hunt. The bill was enrolled on May 23, 2018 — the final check of the text before it goes to the governor — and an enrolled bill amendment (2018-2107e) was adopted on a voice vote to correct technical errors found after passage. The governor signed it on July 2, 2018, making it Chapter 350 of the session laws.

Hearings and Sessions

January 17, 2018, 1:15 PM: public hearing, House Commerce and Consumer Affairs, LOB 302
January 30, 2018, 11:15 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
February 20, 2018, 9:30 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
February 21, 2018: executive session, House Commerce and Consumer Affairs, LOB 302
February 21, 2018, 9:30 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
March 20, 2018, 1:15 PM: hearing, Senate Health and Human Services, LOB 101

Votes

March 6, 2018, House: Ought to Pass with Amendment — yeas 312, nays 17, passed
April 26, 2018, Senate: Ought to Pass with Amendment 2018-1599s — voice vote, passed
May 10, 2018, House: House Concurs with Senate Amendment 1599s — voice vote, passed

The Docket

January 3, 2018: Introduced 01/03/2018 and referred to Commerce and Consumer Affairs
January 17, 2018: Public Hearing: 01/17/2018 01:15 PM LOB 302
January 30, 2018: Subcommittee Work Session: 01/30/2018 11:15 AM LOB 302
January 30, 2018: Subcommittee Work Session: 01/30/2018 01:15 PM LOB 302
February 20, 2018: Subcommittee Work Session: 02/20/2018 09:30 AM LOB 302
February 21, 2018: Subcommittee Work Session: 02/21/2018 09:30 AM LOB 302
February 21, 2018: Executive Session: 02/21/2018 LOB 302
March 6, 2018: Committee Report: Ought to Pass with Amendment #2018-0782h (NT) for 03/06/2018 (Vote 18-1; RC)
March 6, 2018: Amendment #2018-0782h : AA VV 03/06/2018
March 6, 2018: Ought to Pass with Amendment 0782h: MA RC 312-17 03/06/2018
March 8, 2018: Introduced 03/08/2018 and Referred to Health and Human Services
March 20, 2018: Hearing: 03/20/2018, Room 101, LOB, 01:15 pm
April 26, 2018: Committee Report: Ought to Pass with Amendment #2018-1599s , 04/26/2018
April 26, 2018: Committee Amendment #2018-1599s , AA, VV; 04/26/2018
April 26, 2018: Ought to Pass with Amendment 2018-1599s, MA, VV; OT3rdg; 04/26/2018
May 10, 2018: House Concurs with Senate Amendment 1599s (Rep. Hunt): MA VV 05/10/2018
May 23, 2018: Enrolled Bill Amendment #2018-2107e Adopted, VV, (In recess of 05/23/2018)
May 23, 2018: Enrolled Bill Amendment #2018-2107e : AA VV 05/23/2018
May 23, 2018: Enrolled 05/23/2018
May 23, 2018: Enrolled (In recess 05/23/2018)
July 2, 2018: Signed by Governor Sununu 07/02/2018; Chapter 350; I. Sec 2 eff 11/01/2018;II. Rem eff 07/02/2018

Laws It Would Change

Related Bills

SB 226-FN (2019): relative to registration of pharmacy benefit managers, and reestablishing the commission to study greater transparency in pharmaceutical costs and drug rebate programs.
SB 32 (2019): reestablishing the commission to study greater transparency in pharmaceutical costs and drug rebate programs.